Sumitomo Mitsui Trust Group Inc. decreased its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 3.1% in the 3rd quarter, Holdings Channel reports. The firm owned 247,637 shares of the insurance provider’s stock after selling 7,800 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Humana were worth $94,491,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Manning & Napier Advisors LLC bought a new position in shares of Humana in the 2nd quarter worth about $1,412,000. Vista Investment Partners LLC bought a new stake in shares of Humana during the 3rd quarter valued at about $3,254,000. The Manufacturers Life Insurance Company boosted its position in shares of Humana by 10.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 70,185 shares of the insurance provider’s stock valued at $27,879,000 after purchasing an additional 6,690 shares in the last quarter. Pzena Investment Management LLC bought a new stake in shares of Humana during the 2nd quarter valued at about $1,749,014,000. Finally, Ameritas Advisory Services LLC acquired a new stake in Humana during the second quarter worth approximately $1,709,000. Institutional investors own 92.38% of the company’s stock.
Humana Trading Down 1.1%
NYSE:HUM opened at $409.81 on Tuesday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The firm has a 50-day moving average of $401.53 and a 200-day moving average of $309.38. The company has a market cap of $49.21 billion, a PE ratio of 23.95, a PEG ratio of 2.54 and a beta of 0.74. Humana Inc. has a one year low of $163.11 and a one year high of $456.50.
Humana Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 24th will be given a dividend of $0.8850 per share. The ex-dividend date of this dividend is Thursday, December 24th. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. Humana’s dividend payout ratio (DPR) is currently 33.49%.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on HUM shares. Bank of America upgraded Humana from a “neutral” rating to a “buy” rating and set a $500.00 price target on the stock in a report on Wednesday, July 29th. Raymond James Financial upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $520.00 target price on the stock in a research report on Monday, October 12th. HSBC lowered shares of Humana to a “hold” rating in a research note on Thursday, July 30th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Humana in a report on Thursday, July 30th. They issued a “hold” rating for the company. Finally, Cantor Fitzgerald upgraded shares of Humana from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $300.00 to $460.00 in a report on Wednesday, October 7th. Twenty-one analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $453.30.
View Our Latest Research Report on HUM
About Humana
Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.
Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.
Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.
Further Reading
- Five stocks we like better than Humana
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
